{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:45:16Z","timestamp":1793313916941,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejmech.2021.113487","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T07:20:37Z","timestamp":1619162437000},"page":"113487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies"],"prefix":"10.1016","volume":"220","author":[{"given":"Meizhu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangxing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113487_bib1","first-page":"1","article-title":"Cancer incidence and mortality in China, 2014","volume":"30","author":"Chen","year":"2018","journal-title":"Chin. J. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.biopha.2018.04.099","article-title":"Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells","volume":"103","author":"Mou","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113487_bib3","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160470","article-title":"CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met\/PI3K\/Akt and GRP78 signalling in ovarian cancer cells","volume":"37","author":"Deying","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2021.113487_bib4","doi-asserted-by":"crossref","first-page":"49384","DOI":"10.18632\/oncotarget.9891","article-title":"PA-MSHA in combination with EGFR tyrosine kinase inhibitor: a new strategy to overcome the drug resistance of non-small cell lung cancer cells","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12272-013-0276-2","article-title":"Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system","volume":"37","author":"Kibria","year":"2014","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2021.113487_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1013172910858","article-title":"Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches","volume":"20","author":"Kerbel","year":"2001","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.ejmech.2021.113487_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12866-015-0488-3","article-title":"Variability in gene cassette patterns of class 1 and 2 integrons associated with multi drug resistance patterns in Staphylococcus aureus clinical isolates in Tehran-Iran","volume":"15","author":"Mostafa","year":"2015","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ejmech.2021.113487_bib8","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.18632\/oncotarget.7073","article-title":"Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib9","first-page":"71","article-title":"Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp","volume":"15","author":"Alfarouk","year":"2015","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.ejmech.2021.113487_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/bjc.2012.40","article-title":"Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria","volume":"106","author":"Roundhill","year":"2012","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113487_bib11","first-page":"1590","article-title":"Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine","volume":"6","author":"Fanciulli","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2006.03.017","article-title":"Regulation of MDK expression in human cancer cells modulates sensitivities to various anticancer drugs: MDK overexpression confers to a multi-drug resistance","volume":"247","author":"Kang","year":"2007","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113487_bib13","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1038\/onc.2014.25","article-title":"Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model","volume":"33","author":"Nguyen","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113487_bib14","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1091\/mbc.e08-12-1249","article-title":"ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2021.113487_bib15","first-page":"1361","article-title":"Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy","volume":"188","author":"Jiang","year":"2012","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2021.113487_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2021.113487_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2015.11.004","article-title":"Adjuvant therapy for pancreas cancer in an era of value based cancer care","volume":"42","author":"Ahn","year":"2016","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.ejmech.2021.113487_bib18","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1158\/0008-5472.CAN-12-0658","article-title":"Sorafenib has potent antitumor activity against multiple myeloma in\u00a0vitro, ex\u00a0vivo, and in\u00a0vivo in the 5T33MM mouse model","volume":"72","author":"Kharaziha","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/CAD.0000000000000472","article-title":"2-Deoxy-D-glucose suppresses the migration and reverses the drug resistance of colon cancer cells through ADAM expression regulation","volume":"28","author":"Park","year":"2017","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.ejmech.2021.113487_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbabio.2004.05.007","article-title":"Wages of fear\": transient threefold decrease in intracellular ATP level imposes apoptosis","volume":"1658","author":"Izyumov","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113487_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2021.113487_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2021.113487_bib23","first-page":"239","article-title":"Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review, Taiwan","volume":"48","author":"Liu","year":"2009","journal-title":"J.\u00a0Obstet. Gynecol."},{"key":"10.1016\/j.ejmech.2021.113487_bib24","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1002\/pmic.201200228","article-title":"Carbon source-induced reprogramming of the cell wall proteome and secretome modulates the adherence and drug resistance of the fungal pathogen Candida albicans","volume":"12","author":"Ene","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.ejmech.2021.113487_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2016.03.021","article-title":"Rapid assessment of drug resistance of cancer cells to gefitinib and carboplatin using optical imaging","volume":"504","author":"Luo","year":"2016","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2021.113487_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2021.113487_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00280-006-0291-9","article-title":"Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia","volume":"59","author":"Cao","year":"2007","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113487_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.404","article-title":"AMPK, a key regulator of metabolic\/energy homeostasis and mitochondrial biogenesis in cancer cells","volume":"7","author":"Chaube","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113487_bib29","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bph.13422","article-title":"The Warburg effect and drug resistance","volume":"173","author":"Bhattacharya","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113487_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17530050903266830","article-title":"Early detection of cancer: immunoassays for plasma tumor markers","volume":"3","author":"Meany","year":"2009","journal-title":"Expert Opin. Med. Diagn."},{"key":"10.1016\/j.ejmech.2021.113487_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/0008-5472.613.65.2","article-title":"Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia","volume":"65","author":"Xu","year":"2005","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/0008-5472.CAN-11-1674","article-title":"Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells","volume":"72","author":"Zhou","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2011.00049","article-title":"Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review","volume":"2","author":"Porporato","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113487_bib34","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1074\/jbc.M212392200","article-title":"Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing","volume":"278","author":"Munoz-Pinedo","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2016.02.018","article-title":"mTORC1-Dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells","volume":"29","author":"Pusapati","year":"2016","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2021.113487_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fphys.2017.00013","article-title":"Cellular signaling pathways in insulin resistance-systems biology analyses of microarray dataset reveals new drug target gene signatures of type 2 diabetes mellitus","volume":"8","author":"Muhammad","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2021.113487_bib37","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrd1175","article-title":"Anti-TNF-alpha therapies: the next generation","volume":"2","author":"Palladino","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113487_bib38","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.chembiol.2019.06.005","article-title":"Inhibition of glucose transporters and glutaminase synergistically impairs tumor cell growth","volume":"26","author":"Reckzeh","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ejmech.2021.113487_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-016-0289-9","article-title":"Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis","volume":"8","author":"Huang","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.ejmech.2021.113487_bib40","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.2337\/db16-0060","article-title":"Glucose-6-Phosphate dehydrogenase deficiency improves insulin resistance with reduced adipose tissue inflammation in obesity","volume":"65","author":"Ham","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2021.113487_bib41","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db14-0287","article-title":"Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease","volume":"63","author":"Yarchoan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2021.113487_bib42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2015.07.041","article-title":"Parameters of glucose and lipid metabolism at the fasted state in drug-naive first-episode patients with psychosis: evidence for insulin resistance","volume":"229","author":"Petrikis","year":"2015","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib43","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113487_bib44","article-title":"LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells, Mol. Cell","volume":"54","author":"Li","year":"2020","journal-title":"Probe"},{"key":"10.1016\/j.ejmech.2021.113487_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108195","article-title":"Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment","volume":"498","author":"Fu","year":"2020","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1568026618666180523105234","article-title":"Targeting key transporters in tumor glycolysis as a novel anticancer strategy","volume":"18","author":"Shi","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib47","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/iub.2133","article-title":"Trolox prevents high glucose-induced apoptosis in rat myocardial H9c2 cells by regulating GLUT-4 and antioxidant defense mechanism","volume":"71","author":"Davargaon","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejmech.2021.113487_bib48","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41557-018-0132-6","article-title":"Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3","volume":"10","author":"Karageorgis","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib49","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/bph.12668","article-title":"Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype","volume":"171","author":"Bhattacharya","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113487_bib50","doi-asserted-by":"crossref","first-page":"61093","DOI":"10.18632\/oncotarget.17862","article-title":"Endoplasmic reticulum stress induces autophagy and apoptosis while inhibiting proliferation and drug resistance in multiple myeloma through the PI3K\/Akt\/mTOR signaling pathway","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1476-5381.2009.00345.x","article-title":"Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells","volume":"158","author":"Klawitter","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113487_bib52","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-11-3024","article-title":"Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells","volume":"72","author":"Tamada","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib53","doi-asserted-by":"crossref","first-page":"129760","DOI":"10.1016\/j.bbagen.2020.129760","article-title":"Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment","volume":"1865","author":"Balbonia","year":"2021","journal-title":"BBA-Gen. Subjects."},{"key":"10.1016\/j.ejmech.2021.113487_bib54","first-page":"1","article-title":"Metabolic plasticity imparts erlotinibresistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase","volume":"8","author":"Sharma","year":"2020","journal-title":"Canc. Metabol."},{"key":"10.1016\/j.ejmech.2021.113487_bib55","doi-asserted-by":"crossref","unstructured":"F. Marcucci, C. Rumio, Glycolysis-induced drug resistance in tumors-A response to danger signals? Neoplasia, 23 (2021), 2340245.","DOI":"10.1016\/j.neo.2020.12.009"},{"key":"10.1016\/j.ejmech.2021.113487_bib56","doi-asserted-by":"crossref","first-page":"17405","DOI":"10.1074\/jbc.M116.713735","article-title":"Transforming growth factor beta mediates drug resistance by regulating the expression of pyruvate dehydrogenase kinase 4 in colorectal cancer","volume":"291","author":"Zhang","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib57","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-014-9531-3","article-title":"Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy","volume":"33","author":"Fais","year":"2014","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.ejmech.2021.113487_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10863-007-9086-x","article-title":"The Warburg effect and its cancer therapeutic implications","volume":"39","author":"Chen","year":"2007","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.ejmech.2021.113487_bib59","doi-asserted-by":"crossref","unstructured":"K. Xu, N. Yin, M. Peng, E.G. Stamatiades, A. Shyu, P. Li, X. Zhang, M.H. Do., Z.Q. Wang, K.J. Capistrano, C. Chou, A.G. Levine, A.Y. Rudensky, M.O. Li, Glycolysis fuels phosphoinositide 3-kinase signling to bloster T cell immunity, Science, 371 (2021), 405-410.","DOI":"10.1126\/science.abb2683"},{"key":"10.1016\/j.ejmech.2021.113487_bib60","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.4161\/cc.10.15.16584","article-title":"Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells","volume":"10","author":"Martinez-Outschoorn","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2021.113487_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drup.2014.10.003","article-title":"Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms","volume":"17","author":"van der Mijn","year":"2014","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2021.113487_bib62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrd1751","article-title":"Glycans in cancer and inflammation--potential for therapeutics and diagnostics","volume":"4","author":"Dube","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113487_bib63","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1074\/jbc.RA119.008969","article-title":"Klebsiella pneumoniae O1 and O2ac antigens provide prototypes for an unusual strategy for polysaccharide antigen diversification","volume":"294","author":"Kelly","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib64","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/glycob\/11.12.1051","article-title":"Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis","volume":"11","author":"Wang","year":"2001","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejmech.2021.113487_bib65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev.biochem.72.121801.161809","article-title":"A\u00a0genetic approach to Mammalian glycan function","volume":"72","author":"Lowe","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2021.113487_bib66","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","article-title":"Glycosylation in cellular mechanisms of health and disease","volume":"126","author":"Ohtsubo","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113487_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1559-0275-8-7","article-title":"Aberrant glycosylation associated with enzymes as cancer biomarkers","volume":"8","author":"Meany","year":"2011","journal-title":"Clin. Proteonomics"},{"key":"10.1016\/j.ejmech.2021.113487_bib68","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.2009.22.9088","article-title":"Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial","volume":"28","author":"Burnett","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2021.113487_bib69","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2016.04.008","article-title":"Disease-associated glycans on cell surface proteins","volume":"51","author":"Takahashi","year":"2016","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejmech.2021.113487_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-2571(97)00011-3","article-title":"Gene expression and regulation of N-acetylglucosaminyltransferases III and V in cancer tissues","volume":"38","author":"Taniguchi","year":"1998","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ejmech.2021.113487_bib71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/iub.1133","article-title":"Functional roles of glycogene and N-glycan in multidrug resistance of human breast cancer cells","volume":"65","author":"Ma","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejmech.2021.113487_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2133\/dmpk.DMPK-11-RV-098","article-title":"Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2)","volume":"27","author":"Ieiri","year":"2012","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2021.113487_bib73","doi-asserted-by":"crossref","first-page":"11845","DOI":"10.1074\/jbc.M112.405993","article-title":"Reduction of the ST6 beta-galactosamide alpha-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2\/cell adhesion molecule 1 and enhancement of ErbB2\/ErbB3 signaling by microRNA-199a","volume":"288","author":"Minami","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-6-32","article-title":"N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma","volume":"6","author":"Kudo","year":"2007","journal-title":"Mol. Canc."},{"key":"10.1016\/j.ejmech.2021.113487_bib75","doi-asserted-by":"crossref","first-page":"40412","DOI":"10.1074\/jbc.M404466200","article-title":"Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells","volume":"279","author":"Norris-Cervetto","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib76","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1128\/MCB.17.9.5453","article-title":"Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters","volume":"17","author":"Nourani","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113487_bib77","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2019.05.053","article-title":"Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance","volume":"180","author":"Yin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib78","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1021\/acs.langmuir.5b00542","article-title":"Self-assembled polymer\/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy","volume":"31","author":"Gong","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.ejmech.2021.113487_bib79","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.18632\/oncotarget.23187","article-title":"Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7\/ADR cells and xenograft models","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib80","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2021.113487_bib81","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jac\/dkt414","article-title":"Exposure of HIV-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness","volume":"69","author":"Mathys","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113487_bib82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4161\/cbt.5.7.2970","article-title":"Glucose regulated proteins in cancer progression, drug resistance and immunotherapy","volume":"5","author":"Fu","year":"2006","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.ejmech.2021.113487_bib83","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3892\/ijo.2012.1471","article-title":"Co-silencing of Birc5 (survivin) and Hspa5 (Grp78) induces apoptosis in hepatoma cells more efficiently than single gene interference","volume":"41","author":"Wang","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2021.113487_bib84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1039\/C2MB25512J","article-title":"Yeast cells with impaired drug resistance accumulate glycerol and glucose","volume":"10","author":"Dikicioglu","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2021.113487_bib85","doi-asserted-by":"crossref","first-page":"26104","DOI":"10.18632\/oncotarget.4422","article-title":"Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma","volume":"6","author":"Ho","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib86","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/acscentsci.8b00588","article-title":"Oligomannose glycopeptide conjugates elicit antibodies targeting the glycan core rather than its extremities","volume":"5","author":"Nguyen","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2021.113487_bib87","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bjc.1988.291","article-title":"The multidrug resistance phenotype","volume":"58","author":"Kaye","year":"1988","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113487_bib88","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Canc. Prev. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib89","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12885-016-2551-3","article-title":"Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol","volume":"16","author":"Martinez","year":"2016","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejmech.2021.113487_bib90","doi-asserted-by":"crossref","first-page":"40767","DOI":"10.18632\/oncotarget.8194","article-title":"Repurposing metformin for cancer treatment: current clinical studies","volume":"7","author":"Chae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib91","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","article-title":"Metformin: taking away the candy for cancer?","volume":"46","author":"Jalving","year":"2010","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113487_bib92","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fphar.2015.00085","article-title":"Role of transporters in the distribution of platinum-based drugs","volume":"6","author":"Harrach","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113487_bib94","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.111.181297","article-title":"Oxaliplatin transport mediated by organic cation\/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons","volume":"338","author":"Jong","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113487_bib95","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1305321110","article-title":"Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2","volume":"110","author":"Sprowl","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113487_bib96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/CAD.0000000000000459","article-title":"Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells","volume":"28","author":"Wang","year":"2017","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.ejmech.2021.113487_bib97","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejmech.2017.01.032","article-title":"Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: exhibited enhanced safety and preferentially accumulated in cancer cells in\u00a0vitro and in\u00a0vivo","volume":"128","author":"Ma","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib98","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1021\/acs.biochem.8b00095","article-title":"An enzyme-directed imidazoquinoline activated by drug resistance","volume":"57","author":"Burt","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113487_bib99","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11095-019-2673-9","article-title":"Sugar modification enhances cytotoxic activity of PAMAM-doxorubicin conjugate in glucose-deprived MCF-7 cells - possible role of GLUT1 transporter","volume":"36","author":"Sztandera","year":"2019","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2021.113487_bib100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.gt.3301072","article-title":"Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy","volume":"7","author":"Weyel","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejmech.2021.113487_bib101","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/jm00137a001","article-title":"A\u00a0novel connector linkage applicable in prodrug design","volume":"24","author":"Carl","year":"1981","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib102","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/med.21333","article-title":"Targeted prodrug approaches for hormone refractory prostate cancer","volume":"35","author":"Aloysius","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113487_bib103","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02977634","article-title":"Beta-galactoside prodrugs of doxorubicin for application in antibody directed enzyme prodrug therapy\/prodrug monotherapy","volume":"30","author":"Devalapally","year":"2007","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2021.113487_bib104","first-page":"4535","article-title":"Development of doxorubicin resistant rat prostate cancer cell lines","volume":"17","author":"Replogle-Schwab","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ncomms1309","article-title":"alpha-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells","volume":"2","author":"He","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113487_bib106","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1039\/C9OB00826H","article-title":"Tight-binding inhibition of jack bean alpha-mannosidase by glycoimidazole clusters","volume":"17","author":"Pichon","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pep.2014.04.014","article-title":"Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid--monoacylated phosphatidylinositol dimannoside","volume":"100","author":"Svetlikova","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2021.113487_bib108","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1515\/hsz-2014-0302","article-title":"Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways","volume":"396","author":"Hajj","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib109","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ptr.3073","article-title":"Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA\/Dx5","volume":"24","author":"Choi","year":"2010","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/glycob\/cwq028","article-title":"Arabidopsis thaliana ALG3 mutant synthesizes immature oligosaccharides in the ER and accumulates unique N-glycans","volume":"20","author":"Kajiura","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejmech.2021.113487_bib111","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.leu.2403598","article-title":"CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance","volume":"19","author":"Linenberger","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.113487_bib112","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1021\/jo990196p","article-title":"First synthesis of UDP-C-d-galactofuranose","volume":"64","author":"Kovensky","year":"1999","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib113","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0008-6215(01)00146-X","article-title":"Synthesis of beta-D-galactofuranosyl nucleoside analogues. A new type of beta-D-galactofuranosidase inhibitor","volume":"333","author":"Marino","year":"2001","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib114","doi-asserted-by":"crossref","first-page":"18151","DOI":"10.3748\/wjg.v20.i48.18151","article-title":"Colorectal carcinogenesis--update and perspectives","volume":"20","author":"Raskov","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2021.113487_bib115","first-page":"177","article-title":"Colorectal cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2021.113487_bib116","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.phrs.2004.03.003","article-title":"The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats","volume":"50","author":"Yilmaz","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib117","doi-asserted-by":"crossref","first-page":"16847","DOI":"10.18632\/oncotarget.24708","article-title":"Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells","volume":"9","author":"Catanzaro","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib118","first-page":"127","article-title":"siRNA of ADAM17 gene induces apoptosis, proliferation inhibition and enhances the effects of genistein on HepG2 cells","volume":"23","author":"Liu","year":"2009","journal-title":"J.\u00a0Nan Jing Med. Univ."},{"key":"10.1016\/j.ejmech.2021.113487_bib119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00345-013-1091-6","article-title":"D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial","volume":"32","author":"Kranjcec","year":"2014","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejmech.2021.113487_bib120","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0729-3","article-title":"Mannose impairs tumour growth and enhances chemotherapy","volume":"563","author":"Gonzalez","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113487_bib121","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bbadis.2008.11.012","article-title":"The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib","volume":"1792","author":"de Lonlay","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113487_bib122","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2014.06.021","article-title":"Mannose metabolism: more than meets the eye","volume":"453","author":"Sharma","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113487_bib123","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nchembio.1459","article-title":"Homogeneous low-molecular-weight heparins with reversible anticoagulant activity","volume":"10","author":"Xu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113487_bib124","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1207478","article-title":"Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins","volume":"334","author":"Xu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113487_bib125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bcp.2015.07.013","article-title":"Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells","volume":"97","author":"Pfankuchen","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113487_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041035","article-title":"Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation","volume":"7","author":"Niu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113487_bib127","doi-asserted-by":"crossref","first-page":"16231","DOI":"10.1038\/s41598-017-13431-y","article-title":"Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"Suppl 3","key":"10.1016\/j.ejmech.2021.113487_bib128","doi-asserted-by":"crossref","first-page":"S497","DOI":"10.1007\/s10545-010-9252-x","article-title":"Seizures and stupor during intravenous mannose therapy in a patient with CDG syndrome type 1b (MPI-CDG)","volume":"33","author":"Schroeder","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmech.2021.113487_bib129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cbt.27148","article-title":"Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells","volume":"15","author":"Chen","year":"2014","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.ejmech.2021.113487_bib130","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/35039551","article-title":"Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin","volume":"407","author":"Pellegrini","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113487_bib131","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood-2015-05-646497","article-title":"Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells","volume":"127","author":"Larrue","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113487_bib132","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.matbio.2016.03.006","article-title":"Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype","volume":"55","author":"Ramani","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejmech.2021.113487_bib133","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3892\/ol.2015.3508","article-title":"Interplay between unfolded protein response and autophagy promotes tumor drug resistance","volume":"10","author":"Yan","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2021.113487_bib134","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1158\/0008-5472.CAN-15-0037","article-title":"Heparanase enhances tumor growth and chemoresistance by promoting autophagy","volume":"75","author":"Shteingauz","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113487_bib135","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1080\/15548627.2015.1115174","article-title":"Function from within: autophagy induction by HPSE\/heparanase--new possibilities for intervention","volume":"11","author":"Ilan","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2021.113487_bib136","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/jm050800q","article-title":"Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance","volume":"49","author":"Fang","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113487_bib137","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood.V88.2.633.bloodjournal882633","article-title":"The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines","volume":"88","author":"Consoli","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113487_bib138","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001813-199302000-00005","article-title":"Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity","volume":"4","author":"Priebe","year":"1993","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.ejmech.2021.113487_bib139","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1021\/ja982414m","article-title":"Reconstruction of vancomycin by chemical glycosylation of the pseudoaglycon","volume":"120","author":"Ge","year":"1998","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113487_bib140","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1126\/science.284.5413.507","article-title":"Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala","volume":"284","author":"Ge","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113487_bib141","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/ijc.22227","article-title":"Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer","volume":"119","author":"Ramos-Montoya","year":"2006","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113487_bib142","first-page":"1000107","article-title":"Endoplasmic reticulum stress and related pathological processes","volume":"1","author":"Mei","year":"2013","journal-title":"J.\u00a0Pharmacol. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2021.113487_bib143","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4161\/auto.7.10.16818","article-title":"Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis","volume":"7","author":"Shi","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2021.113487_bib144","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd1521","article-title":"Glycomics: a pathway to a class of new and improved therapeutics","volume":"3","author":"Shriver","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113487_bib145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/cpr.12221","article-title":"Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress","volume":"48","author":"Zhong","year":"2015","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ejmech.2021.113487_bib146","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4161\/auto.7.10.17029","article-title":"Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells","volume":"7","author":"Bareford","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2021.113487_bib147","doi-asserted-by":"crossref","first-page":"37066","DOI":"10.18632\/oncotarget.5797","article-title":"Sorafenib-induced defective autophagy promotes cell death by necroptosis","volume":"6","author":"Kharaziha","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113487_bib148","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13287-019-1225-x","article-title":"Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury","volume":"10","author":"Hu","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejmech.2021.113487_bib149","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12906-018-2115-y","article-title":"Citral induced apoptosis in MDA-MB-231 spheroid cells","volume":"18","author":"Nigjeh","year":"2018","journal-title":"BMC Compl. Alternative Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:30:43Z","timestamp":1759329043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":149,"alternative-id":["S0223523421003366"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113487","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113487"}}